BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Diagnosis
11 results:

  • 1. Patterns of emergency department visits before diagnosis with digestive neuroendocrine neoplasms.
    Abdel-Rahman O; Ghosh S
    Int J Colorectal Dis; 2023 May; 38(1):148. PubMed ID: 37253995
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.
    Niloofa R; De Zoysa MI; Seneviratne LS
    J Cancer Res Ther; 2021; 17(4):819-833. PubMed ID: 34528528
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.
    Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
    Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effects of pim3 in prognosis of colon cancer.
    Zhou Y; Zhou YN; Liu SX; Wang J; Ji R; Yan X
    Clin Transl Oncol; 2021 Oct; 23(10):2163-2170. PubMed ID: 33928496
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Label-Free Nanoplasmonic Biosensing of cancer Biomarkers for Clinical diagnosis.
    Portela A; Peláez EC; Calvo-Lozano O; Estévez MC; Lechuga LM
    Methods Mol Biol; 2019; 2027():115-140. PubMed ID: 31309477
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    J Geriatr Oncol; 2019 Sep; 10(5):705-708. PubMed ID: 30795923
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Potential Medication-Related Problems in Older Breast, Colon, and Lung cancer Patients in the United States.
    Lund JL; Sanoff HK; Peacock Hinton S; Muss HB; Pate V; Stürmer T
    Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):41-49. PubMed ID: 28978563
    [No Abstract]    [Full Text] [Related]  

  • 8. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. pim-2 Modulates Aerobic Glycolysis and Energy Production during the Development of colorectal Tumors.
    Zhang XH; Yu HL; Wang FJ; Han YL; Yang WL
    Int J Med Sci; 2015; 12(6):487-93. PubMed ID: 26078709
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays.
    Barderas R; Babel I; Díaz-Uriarte R; Moreno V; Suárez A; Bonilla F; Villar-Vázquez R; Capellá G; Casal JI
    J Proteomics; 2012 Aug; 75(15):4647-55. PubMed ID: 22465712
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.